UACR normal range and high result interpretation: What it means for kidney aging

Q: What is a dangerous UACR level?

Any result ≥300 mg/g (≥30 mg/mmol) — KDIGO A3, historically "macroalbuminuria" — is clinically significant and should prompt a nephrology referral once confirmed on repeat sampling. Values in the nephrotic range (>2200 mg/g) require urgent evaluation. That said, "dangerous" is context-dependent: a UACR of 400 mg/g in a person with uncontrolled diabetes, hypertension, and declining eGFR is a different clinical picture from the same value in someone with well-controlled metabolic parameters, and the two warrant different urgencies of response.

The urine albumin-to-creatinine ratio — UACR — is one of the most underrated early markers in modern lab medicine. It rises before eGFR drops, flagging endothelial strain at a stage when the kidney is still structurally intact and the damage is often reversible. Most people have never heard of it. Most lab reports list it without an explanation. And yet, among all routine tests, it is the one most likely to pick up the earliest signal of metabolic and vascular trouble.

If you are reading this, you probably just opened a lab report showing something like “UACR 35 mg/g” with a red flag next to it. Your doctor may have said “repeat in three months” and left the room. You are left wondering whether you are developing kidney disease, whether that treadmill session the day before skewed the result, or whether this number means something systemic about how fast you are aging.

This article answers those questions. It explains what UACR actually measures, what the KDIGO categories mean, how to distinguish a transient spike from persistent albuminuria, and what the result says about your cardiovascular and biological-age trajectory — without overstating the risk of a single abnormal reading.

What you’ll learn:

What a normal UACR is and what A1, A2, and A3 mean under the 2024 KDIGO framework
Why a high UACR is a vascular marker, not just a “kidney number”
Common reasons a single sample can be falsely elevated
The concrete next steps after a high result, from repeat testing to specialist referral

Quick answer

Normal UACR is <30 mg/g (<3 mg/mmol). A result of 30–300 mg/g (3–30 mg/mmol) is A2 moderately increased albuminuria (historically “microalbuminuria”). A result >300 mg/g (>30 mg/mmol) is A3 severely increased albuminuria (historically “macroalbuminuria”). A single elevated value is not a diagnosis: confirm with at least one repeat sample, ideally a first-morning void, and consider persistent albuminuria only when 2 of 3 samples over ~3 months are abnormal.

What UACR is and what it measures

UACR stands for urine albumin-to-creatinine ratio. It is a spot-urine test that measures how much albumin — the main plasma protein — is leaking into your urine, normalized to the amount of creatinine in the same sample.

Healthy glomeruli act as precision sieves. Water, salts, and small waste molecules pass through into the urine; large proteins like albumin stay in the bloodstream. When the glomerular filtration barrier is stressed — by high blood pressure, hyperglycemia, inflammation, or direct endothelial damage — small amounts of albumin begin to slip through. This leak is called albuminuria.

Quick definition: Albuminuria is the presence of abnormal amounts of albumin in urine. UACR quantifies it from a spot sample, avoiding the need for a 24-hour urine collection.

Why the ratio, not raw albumin

Urine concentration varies with hydration, time of day, and recent fluid intake. A well-hydrated person produces dilute urine with low albumin per milliliter; a dehydrated person produces concentrated urine with high albumin per milliliter — even if total daily albumin loss is identical.

Creatinine excretion, in contrast, is relatively constant over 24 hours for a given person (it reflects muscle mass and filtration). Dividing urine albumin by urine creatinine effectively normalizes for hydration, producing a ratio that correlates closely with 24-hour albumin excretion — without the hassle of a timed collection.

UACR normal range: KDIGO categories A1, A2, A3

The 2024 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD classifies albuminuria into three categories. Both units are in widespread use internationally — mg/g is common in the United States; mg/mmol is common in Europe and the UK.

KDIGO category	UACR (mg/g)	UACR (mg/mmol)	Historical term	What it represents
A1	<30	<3	Normal to mildly increased	Normal glomerular barrier function
A2	30–300	3–30	Microalbuminuria	Moderately increased albuminuria — early endothelial/glomerular stress
A3	>300	>30	Macroalbuminuria	Severely increased albuminuria — established glomerular damage

A few clarifications that the table does not capture:

The historical label “microalbuminuria” was retired by KDIGO because it suggested a benign, small-quantity condition. A2 is not benign: it is independently associated with a roughly 2–4× increase in cardiovascular and all-cause mortality compared to A1, even when eGFR is normal.
Some sources subdivide A1 into “optimal” (<10 mg/g) and “high-normal” (10–30 mg/g). There is reasonable evidence that risk rises gradually across this range rather than starting abruptly at 30 mg/g — the threshold is a clinical convenience, not a biological cliff.
Nephrotic-range proteinuria (UACR >2200 mg/g, or >220 mg/mmol) is a separate severity tier that almost always warrants urgent nephrology evaluation.

What a high UACR actually means

The first instinct after a high UACR is to think “my kidneys are failing.” That is usually the wrong frame.

UACR is better understood as a window onto systemic vascular health. The glomerulus is a specialized capillary bed, and the same biology that damages it — endothelial dysfunction, oxidative stress, loss of the glycocalyx, basement membrane glycation — is simultaneously damaging capillaries elsewhere: retina, heart, brain, skin. Albumin leakage into urine is often the first detectable downstream signal of a generalized vascular problem.

That is why elevated UACR predicts:

Cardiovascular events (myocardial infarction, stroke, heart failure) independently of blood pressure and cholesterol
Progression to chronic kidney disease and eventual eGFR decline
All-cause mortality, with risk increasing roughly log-linearly across the UACR spectrum

Gansevoort and colleagues (2013), pooling data from more than 1 million participants across the CKD Prognosis Consortium, demonstrated that albuminuria predicts both kidney outcomes and cardiovascular mortality at UACR values well below the classical 30 mg/g threshold, and that it adds prognostic information on top of eGFR at every stage.

In other words: a UACR of 35 mg/g in an otherwise healthy 45-year-old is not a harbinger of imminent dialysis. It is a flag that the vascular bed — including the glomerular one — is under strain, and that upstream drivers (blood pressure, glucose, visceral adiposity, inflammation) deserve attention now, while the damage is still largely reversible.

Common causes of transient elevation

Before interpreting any single UACR, rule out the long list of benign or temporary causes that can push a healthy kidney’s result above 30 mg/g:

Vigorous exercise within 24 hours. Running, lifting, or high-intensity intervals can transiently increase glomerular permeability and produce “exercise-induced albuminuria.” Effect typically resolves within 24–48 hours.
Fever or acute infection. Viral illness, flu, COVID, or any systemic inflammatory state can temporarily increase albumin leak.
Urinary tract infection (UTI). Pyuria and bacteriuria inflate both protein and albumin readings. Always rule out UTI with a urinalysis before accepting a high UACR.
Dehydration or heat stress. Counterintuitively, severe dehydration can distort the ratio in either direction depending on how creatinine and albumin excretion shift.
Menstrual contamination. Menstrual blood contains albumin and will artifactually elevate UACR. Repeat the test outside menses.
Very high protein intake the day before. A 300 g ribeye at dinner can transiently raise glomerular filtration pressure and albumin excretion.
Uncontrolled hyperglycemia or acute blood pressure spike. Transient metabolic extremes cause transient albumin leak.
Orthostatic proteinuria. Mostly in adolescents and young adults: albumin appears in urine only when upright, disappears in recumbent first-morning samples.
Recent decongestive or anti-inflammatory medication use. NSAIDs in particular can alter renal hemodynamics.

This is why the first-morning void is considered the gold-standard sample: the patient has been recumbent, fasting, and unstressed for several hours, minimizing most of these confounders.

When a high result is persistent

KDIGO defines persistent albuminuria as elevated UACR in at least 2 of 3 samples taken over a period of about 3 months. This is the threshold that shifts the interpretation from “possible artifact” to “real finding that warrants a management plan.”

Practical protocol after a first abnormal UACR:

Repeat the test within a few weeks using a first-morning void.
Rule out reversible causes with a concurrent urinalysis (to exclude UTI, hematuria, pyuria) and by avoiding vigorous exercise for 24 hours before the test.
Confirm with a third sample if the first two disagree.
If 2 of 3 samples are ≥30 mg/g, treat as persistent albuminuria and move to workup.

Persistence matters because management decisions — starting an ACE inhibitor or ARB, initiating SGLT2 therapy in selected patients, tightening blood pressure targets, referring to nephrology — are made on the basis of confirmed, persistent albuminuria, not a single spot reading.

What to do next

If your repeat UACR confirms persistent A2 or A3 albuminuria, the workup is straightforward and largely done from blood and urine.

1. Confirm and classify. At minimum, obtain:

A full longevity-oriented blood panel including fasting glucose and HbA1c, a lipid panel, and markers of inflammation
Serum creatinine with eGFR; in elderly or sarcopenic patients, add cystatin C for a more accurate eGFR estimate. If cystatin C comes back high while creatinine remains normal, use our guide to high cystatin C with normal creatinine to frame the follow-up.
Urinalysis with microscopy to exclude hematuria, casts, or infection

2. Check blood pressure rigorously. Office blood pressure is not enough. Home or 24-hour ambulatory measurements are strongly preferred. Hypertension is both a cause and a consequence of albuminuria, and controlling it is the single most effective intervention for reducing UACR.

3. Assess metabolic status. Diabetes and prediabetes are the leading drivers of albuminuria globally. If HbA1c is ≥5.7% or fasting glucose is ≥100 mg/dL, the albuminuria may be an early sign of diabetic kidney disease.

4. Review medications. NSAIDs, certain decongestants, and some herbal supplements can aggravate glomerular stress. Discuss with your physician.

5. Know the referral thresholds. The 2024 KDIGO guideline recommends nephrology referral for:

UACR ≥300 mg/g (A3) on persistent sampling
A combination of A2 albuminuria and eGFR <60 mL/min/1.73 m²
Rapidly progressive eGFR decline
Unexplained hematuria with albuminuria
Any suspicion of glomerulonephritis or nephrotic syndrome

6. Lifestyle levers that move the needle. The strongest non-pharmacological interventions for lowering UACR are: sustained blood pressure control (target typically <130/80 mmHg if tolerated), glycemic control, weight reduction if overweight, reducing sodium intake to <2 g/day, smoking cessation, and moderate (not excessive) dietary protein. None of these is a magic bullet in isolation; stacked, they can halve UACR over several months in early-stage albuminuria.

Why UACR matters for biological age and longevity

Kidney function is not a side story in biological aging — it is one of the central plotlines. The kidney is a capillary-rich, metabolically demanding organ that integrates the consequences of decades of blood pressure, glycemia, visceral fat, and inflammation. When the glomerular filtration barrier starts to leak albumin, it is reporting on the state of the entire vascular tree.

Two findings make this concrete:

Albuminuria predicts mortality independently of eGFR. In the Gansevoort 2013 meta-analysis, a person with normal eGFR but UACR of 300 mg/g had higher cardiovascular and all-cause mortality than a person with eGFR of 45 mL/min/1.73 m² and UACR <10 mg/g. The protein leak carries information that the filtration rate alone misses.
UACR tracks biological, not chronological, age. Two 55-year-olds with identical eGFR but UACRs of 5 vs 45 mg/g have materially different vascular trajectories — the latter more closely resembles a 65-year-old in terms of incident cardiovascular events over the next decade.

This is why, when we think about kidney markers in the context of biological-age algorithms like PhenoAge, we consider not only creatinine and eGFR but also the albumin-leak signal that UACR provides. The two answer different questions: eGFR asks “how much are you filtering?”; UACR asks “how intact is the filter?” Biological aging degrades both, often in that order — filter integrity first, filtration rate later.

A borderline-high UACR is, in this frame, one of the most actionable signals in a longevity panel. It flags a vascular process that is often years or decades away from causing overt disease, and it responds well to the same levers — blood pressure, glucose, weight, sodium, smoking, sleep — that drive biological aging more broadly.

How SuperAge contextualizes your kidney risk

SuperAge is built around validated biological-age algorithms, including PhenoAge, which uses markers like creatinine, inflammation, glucose, and blood cell indices to estimate how fast your body is aging. Kidney-related biomarkers are not an afterthought in this panel — they are central.

When you log a UACR result alongside your blood work, SuperAge places it in the context of your other markers rather than treating it as an isolated number. A UACR of 40 mg/g means something different in a person with perfectly controlled blood pressure, HbA1c of 5.2%, and low inflammation than it does in someone with borderline hypertension, prediabetes, and elevated CRP. The app surfaces that context, tracks your biological age over time, and lets you see whether the levers you are pulling — sleep, exercise, dietary pattern, weight — are moving the needle.

Kidney aging is slow, silent, and highly modifiable in its early stages. The point of tracking UACR alongside a biological-age framework is to catch the signal early enough to act on it.

Frequently asked questions

What is a dangerous UACR level?

Any result ≥300 mg/g (≥30 mg/mmol) — KDIGO A3, historically “macroalbuminuria” — is clinically significant and should prompt a nephrology referral once confirmed on repeat sampling. Values in the nephrotic range (>2200 mg/g) require urgent evaluation. That said, “dangerous” is context-dependent: a UACR of 400 mg/g in a person with uncontrolled diabetes, hypertension, and declining eGFR is a different clinical picture from the same value in someone with well-controlled metabolic parameters, and the two warrant different urgencies of response.

Can exercise cause high UACR?

Yes. Vigorous exercise within 24 hours of the test — especially running, HIIT, or heavy resistance work — can transiently raise UACR above 30 mg/g in otherwise healthy people. This is called exercise-induced albuminuria and typically resolves within 24–48 hours. Always avoid intense training the day before a UACR test, and prefer a first-morning void after a restful night.

Does high UACR always mean kidney disease?

No. A single elevated UACR can be caused by UTI, fever, dehydration, menstrual contamination, a very high-protein meal, or recent intense exercise. That is why KDIGO defines persistent albuminuria as abnormal in 2 of 3 samples over ~3 months. Only persistent albuminuria — combined with other findings — supports a diagnosis of chronic kidney disease.

How often should UACR be retested?

For most healthy adults with a normal result, every 1–2 years alongside routine blood work is reasonable. If you have diabetes, hypertension, cardiovascular disease, or a family history of kidney disease, annual testing is standard. After a confirmed abnormal result, follow your physician’s schedule — typically every 3–6 months during active management.

Is a UACR of 20 mg/g normal?

Yes, technically — it falls within KDIGO A1. However, some research suggests that risk begins to rise gradually from the very low end of the range, so a UACR of 20 mg/g is not equivalent to a UACR of 5 mg/g in terms of long-term cardiovascular and renal risk. Consider it “high-normal” and a reason to pay attention to blood pressure, glucose, and weight, especially if trending upward over serial tests.

Key takeaways

Normal UACR is <30 mg/g (<3 mg/mmol). 30–300 mg/g is A2; >300 mg/g is A3.
A single abnormal result is not a diagnosis. Confirm with a first-morning void and consider persistence only when 2 of 3 samples over ~3 months are abnormal.
Transient elevations are common — exercise, fever, UTI, menstrual contamination, high-protein meals, and dehydration can all push UACR above 30 mg/g in healthy kidneys.
UACR is a vascular marker, not only a kidney one. It predicts cardiovascular events and all-cause mortality independently of eGFR.
Persistent albuminuria is actionable. Blood pressure control, glycemic control, weight management, sodium reduction, and smoking cessation can meaningfully lower UACR in early stages.
The earlier you catch it, the more reversible it is. UACR rises before eGFR falls; that window is where the biggest gains are made.

This article is for educational purposes only and does not replace professional medical advice. If your UACR is elevated, consult your healthcare provider before making any changes.

Start tracking the kidney marker your panel may be missing

UACR is often missing from basic metabolic panels, yet it is one of the most informative single numbers for early kidney and vascular aging. SuperAge helps you assemble a longevity-oriented panel — including UACR, creatinine, inflammation markers, and metabolic biomarkers — and places your results in the context of a validated biological-age framework.

Download SuperAge on the App Store to start tracking the markers most physicians never discuss.

References

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117–S314.
Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes: a collaborative meta-analysis of general and high-risk population cohorts. Kidney International. 2011;80(1):93–104.
Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. The Lancet Diabetes & Endocrinology. 2015;3(7):514–525.
Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011;80(1):17–28.
Sumida K, Nadkarni GN, Grams ME, et al. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis. Annals of Internal Medicine. 2020;173(6):426–435.

Kidney aging is quiet until it isn’t. UACR is one of the few signals that speaks early — and, when you listen, one of the few you can still reverse.